GlaxoSmithKline plc (GSK) PT Set at GBX 1,800 by Citigroup Inc.
GlaxoSmithKline plc (LON:GSK) has been assigned a GBX 1,800 ($23.50) price target by equities research analysts at Citigroup Inc. in a note issued to investors on Thursday. The brokerage currently has a a “buy” rating on the stock. Citigroup Inc.’s price objective suggests a potential upside of 9.56% from the stock’s current price.
GSK has been the subject of a number of other research reports. Societe Generale lowered GlaxoSmithKline plc to a “sell” rating and increased their price objective for the company from GBX 1,300 ($16.97) to GBX 1,320 ($17.23) in a research note on Thursday, September 8th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a GBX 1,900 ($24.80) price target on shares of GlaxoSmithKline plc in a research note on Tuesday, August 23rd. Liberum Capital reaffirmed a “buy” rating and issued a GBX 1,900 ($24.80) price target on shares of GlaxoSmithKline plc in a research note on Tuesday, September 20th. BNP Paribas lowered GlaxoSmithKline plc to an “underperform” rating and set a GBX 1,520 ($19.84) price target for the company. in a research note on Wednesday, September 14th. Finally, Deutsche Bank AG reaffirmed a “hold” rating and issued a GBX 1,800 ($23.50) price target on shares of GlaxoSmithKline plc in a research note on Friday, September 2nd. Three equities research analysts have rated the stock with a sell rating, sixteen have assigned a hold rating and eight have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of GBX 1,676.44 ($21.88).
Shares of GlaxoSmithKline plc (LON:GSK) opened at 1666.00 on Thursday. The company’s market cap is GBX 80.98 billion. GlaxoSmithKline plc has a 52 week low of GBX 1,261.50 and a 52 week high of GBX 1,716.50. The firm’s 50-day moving average is GBX 1,645.84 and its 200-day moving average is GBX 1,542.41.
The business also recently disclosed a dividend, which will be paid on Thursday, October 13th. Stockholders of record on Thursday, August 11th will be given a dividend of GBX 19 ($0.25) per share. The ex-dividend date is Thursday, August 11th. This represents a dividend yield of 1.12%.
In related news, insider Slaoui,Moncef acquired 28 shares of the stock in a transaction dated Friday, August 12th. The shares were purchased at an average cost of GBX 2,208 ($28.82) per share, with a total value of £618.24 ($807.00). Also, insider Witty,Sir Andrew P sold 10,000 shares of GlaxoSmithKline plc stock in a transaction dated Wednesday, July 27th. The shares were sold at an average price of GBX 1,693 ($22.10), for a total value of £169,300 ($220,989.43).
GlaxoSmithKline plc Company Profile
GlaxoSmithKline plc (GSK) is a healthcare company. The Company is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. The Company’s segments include Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare.
Receive News & Stock Ratings for GlaxoSmithKline plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline plc and related stocks with our FREE daily email newsletter.